Longboard Pharmaceuticals amends bylaws to adopt Universal Proxy Rules and DGCL updates

Longboard Pharmaceuticals, Inc.

Board approved amended bylaws effective Sept 21, 2023 to address SEC Universal Proxy Rule 14a-19.
New rules require nominating stockholders to disclose proxy solicitation intent and provide compliance evidence.
Clarifies number of nominees cannot exceed directors to be elected; requires non-white proxy card for dissidents.
Updates include adjournment procedures, delivery of notices, and other administrative changes per DGCL.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Longboard Pharmaceuticals, Inc.: Amended and restated bylaws to address universal proxy rules and make other updates (effective 2023-09-21).

Change: bylaw amendment
Effective: 2023-09-21

Exact text from the filing

On September 21, 2023, the Board of Directors (the "Board") of Longboard Pharmaceuticals, Inc. (the "Company") approved and adopted an amendment and restatement of the Company's bylaws (as amended and restated, the "Bylaws"), effective as of the date of such approval.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950170-23-049437

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.